Alexandra Uzyumova

Dr. Alexandra Uzyumova


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
IMIgor Maiborodin
Igor Maiborodin
GYGennadiy Yarin
Gennadiy Yarin
SMSergey Marchukov
Sergey Marchukov
AUAlexandra Uzyumova
Alexandra Uzyumova
GLGalina Anatolievna Lapii
Galina Anatolievna Lapii
VMVitalina Maiborodina
Vitalina Maiborodina
The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials.

Verified
Journal Article
Open access
PDF file
IEIgor Aleksandrovich Eisenach
Igor Aleksandrovich Eisenach
GLGalina Anatolievna Lapii
Galina Anatolievna Lapii
AUAlexandra Uzyumova
Alexandra Uzyumova
ELElena Leonidovna Lushnikova
Elena Leonidovna Lushnikova
ВОВиктор Овчинников
Виктор Овчинников
VNVasiliy Anatolievich Naprimerov
Vasiliy Anatolievich Naprimerov
Implants made of biodegradable polymers are replaced by regenerating tissues through inflammation. The changes occurring in tissues and the organism are of practical interest for studying the biocompatibility of the material and searching for systemic markers in the blood that reflect inflammation in peri-implantation tissues. The highly sensitive C-reactive protein (hs-CRP) measurements in blood and morphometric studies of tissue surrounding the implant were carried out in the experiment within three months of implantation of a biopolymer consisting of polycaprolactone (PCL) and polytrimethylene carbonate (PTMC). During the first month, tissue inflammation decreased, and the blood level of hs-CRP did not increase. The polymer biotransformation began in the tissues after a month of implantation and was accompanied by inflammation moving deeper into the matrix. Proliferation of inflammatory cells in tissues was reflected in an increase in the hs-CRP level three months after polymer installation. The result achieved confirmed the polymer’s bioinertness. The level of hs-CRP in the blood of the animals correlated with the level of inflammation in peri-implantation tissues, reflecting the activity of inflammation in the process of polymer biotransformation. This inflammation protein can be recommended for assessing tissue processes following implantation of biopolymers and their biocompatibility.

15 November 2021 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
IMIgor Maiborodin
Igor Maiborodin
MKMarina Klinnikova
Marina Klinnikova
SKSergey Kuzkin
Sergey Kuzkin
VMVitalina Maiborodina
Vitalina Maiborodina
SKSergey Krasil’nikov
Sergey Krasil’nikov
ELElena Lushnikova
Elena Lushnikova
The effect of extracellular vesicles (EVs) of various origins on the heart structures in the time of health and disease has been well studied. At the same time, data on the distribution of EVs throughout the body after introduction into the tissues and the possibility of the influence of these EVs on organs distant from the injection site are practically absent. It is also necessary to note a certain inconsistency in the results of various researchers: from articles on the direct absorption of EVs derived from mesenchymal multipotent stromal cells (MSC EVs) by cardiomyocytes to the data that the heart is inherently immune to drug delivery mediated by nanoparticles. In this regard, the morphological changes in the myocardium of outbred rabbits of both sexes weighing 3–4 kg were studied at various times after experimental trauma of the bone tissue in the proximal condyle of the tibia (PCT) and the use of MSC EVs. As a result of modeling the PCT defect, rabbits develop myocardial edema in the heart muscle by the 3rd day, their lymphatic vessels expand, and then, on the 7th day, the blood vessels become dilated. In the myocardium, the relative and absolute contents of neutrophils, erythrocytes, and macrophages increase, but the percentage of lymphocytes decreases. By day 10, almost all of these changes return to their initial values. The detected transformations of the myocardium are most likely due to the ingress of detritus with the blood flow from the PCT. The use of MSC EVs to influence the regeneration of damaged tissue of PCT promotes earlier dilatation of the blood vessels of the heart with pronounced diapedesis of erythrocytes or even hemorrhages, prolongation of edema, the formation of blood clots in vessels with obliteration of their lumen, sclerotic transformation of vascular walls and paravascular tissues. In the myocardium, the number density of neutrophils, the percentage of lymphocytes, and neutrophils become smaller, with a simultaneous increase in the relative numbers of erythrocytes and macrophages, and changes in the content of macrophages remained until the end of the observation—up to 10 days after the surgery. The discovered effect of MSC EVs is most likely associated with the suppression of the activity of the inflammatory process in the PCT area, which, in turn, was caused by a longer ingress of detritus with blood flow into the myocardium. The absence of statistically significant differences between changes in the myocardium of the left and right ventricles may indicate that both detritus from the surgical site and MSC EVs affect the heart spreading through the coronary artery system.

Verified
Journal Article
Open access
PDF file
IEIgor Aleksandrovich Eisenach
Igor Aleksandrovich Eisenach
GLGalina Anatolievna Lapii
Galina Anatolievna Lapii
AUAlexandra Uzyumova
Alexandra Uzyumova
ELElena Leonidovna Lushnikova
Elena Leonidovna Lushnikova
ВОВиктор Овчинников
Виктор Овчинников
AKAlexey Kuznetsov
Alexey Kuznetsov
In recent decades, the use of polypropylene meshes has been the gold standard in the surgical treatment of muscular corset failure. However, the reasons behind the low percentage of complications and recurrences remain controversial. Tissue hyperreactivity and the immune response to polypropylene may be contributing factors. Measurements of the level of hs-CRP (highly sensitive C-reactive protein) in the blood and morphometric studies of tissues around the implant were carried out for three months after the installation of polypropylene implants in 53 laboratory rats. The research results confirmed the good biocompatibility of polypropylene and the formation of full-fledged connective tissue around polypropylene three months after the installation of the material. The level of hs-CRP in the blood increased slightly, without significant differences, but in some animals, there was a sharp increase in this indicator at 3 months. Such results may indicate the development of hyperreactivity to the implantation of a synthetic material and, with other accompanying factors, lead to the development of complications both at the local tissue and general immune levels.